Clinical Trial Update: Compassionate Use for Subcutaneous (SC) Belimumab

View source ↗

Summary

Compassionate-use program for subcutaneous belimumab in systemic lupus erythematosus has been updated; the program is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BENLYSTA (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Status: NO_LONGER_AVAILABLE